TY - JOUR
T1 - Image quality improvements in C-Arm CT (CACT) for liver oncology applications
T2 - Preliminary study in rabbits
AU - Tacher, Vania
AU - Bhagat, Nikhil
AU - Rao, Pramod P.
AU - Lin, Ming De
AU - Schäfer, Dirk
AU - Noordhoek, Niels
AU - Eshuis, Peter
AU - Radaelli, Alessandro
AU - Liapi, Eleni
AU - Grass, Michael
AU - Geschwind, Jean François
N1 - Funding Information:
Noordhoek, P. Eshuis, A. Radaelli, and M. Grass are Philips employees. J.F. Geschwind is a consultant to Biocompatibles, Bayer Healthcare, Guerbet, Nordion, Merit, Abbott, and Jennerex. The other authors have no relevant financial disclosure. This study was funded by NIH/NCI R01 CA160771, P30 CA006973, Philips Research North America, Briarcliff Manor, NY, USA and the French Society of Radiology (SFR).
PY - 2013/9
Y1 - 2013/9
N2 - Introduction: C-Arm CT (CACT) is a new imaging modality in liver oncology therapy that allows for the acquisition of 3D images intra-procedurally. CACT has been used to enhance intra-arterial therapies for the liver by improving lesion detection, avoiding non-target embolization, and allowing for more selective delivery of agents. However, one of the limitations of this technology is image artifacts created by respiratory motion. Purpose: To determine in this preliminary study improvements in image acquisition, motion compensation, and high resolution 3D reconstruction that can improve CACT image quality (IQ). Material and methods: Three adult male New Zealand white rabbits were used for this study. First, a control rabbit was used to select the best x-ray acquisition imaging protocol and then two rabbits were implanted with liver tumor to further develop 3D image reconstruction and motion compensation algorithms. Results: The best IQ was obtained using the low 80 kVp protocol with motion compensated reconstruction with high resolution and fast acquisition speed (60 fps, 5 s/scan, and 312 images). Conclusion: IQ improved by: (1) decreasing acquisition time, (2) applying motion-compensated reconstruction, and (3) high resolution 3D reconstruction. The findings of this study can be applied to future animal studies and eventually could be translated into the clinical environment.
AB - Introduction: C-Arm CT (CACT) is a new imaging modality in liver oncology therapy that allows for the acquisition of 3D images intra-procedurally. CACT has been used to enhance intra-arterial therapies for the liver by improving lesion detection, avoiding non-target embolization, and allowing for more selective delivery of agents. However, one of the limitations of this technology is image artifacts created by respiratory motion. Purpose: To determine in this preliminary study improvements in image acquisition, motion compensation, and high resolution 3D reconstruction that can improve CACT image quality (IQ). Material and methods: Three adult male New Zealand white rabbits were used for this study. First, a control rabbit was used to select the best x-ray acquisition imaging protocol and then two rabbits were implanted with liver tumor to further develop 3D image reconstruction and motion compensation algorithms. Results: The best IQ was obtained using the low 80 kVp protocol with motion compensated reconstruction with high resolution and fast acquisition speed (60 fps, 5 s/scan, and 312 images). Conclusion: IQ improved by: (1) decreasing acquisition time, (2) applying motion-compensated reconstruction, and (3) high resolution 3D reconstruction. The findings of this study can be applied to future animal studies and eventually could be translated into the clinical environment.
KW - C-arm CT
KW - Interventional oncology
KW - Intra-arterial therapy
KW - TACE
UR - http://www.scopus.com/inward/record.url?scp=84884230259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884230259&partnerID=8YFLogxK
U2 - 10.3109/13645706.2013.788028
DO - 10.3109/13645706.2013.788028
M3 - Article
C2 - 23837536
AN - SCOPUS:84884230259
SN - 1364-5706
VL - 22
SP - 297
EP - 303
JO - Minimally Invasive Therapy and Allied Technologies
JF - Minimally Invasive Therapy and Allied Technologies
IS - 5
ER -